Let's Talk About Health – Ep. 9: Hepatitis: What you need to know

Episodio 9

This episode focuses on hepatitis in the lead-up to World Hepatitis Day (July 28). It features two guests:

  • Dr. Enrique Carrera, a gastroenterologist and hepatologist from Ecuador.
  • Antonio Oñate, a hepatitis C survivor and activist from Mexico.

 


Medical Perspective – Dr. Enrique Carrera

  • What is Hepatitis?
    Hepatitis refers to liver inflammation, often caused by viral infections (types A–E).
  • Prevalence & Severity:
    Hepatitis B and C are the most common and dangerous due to their silent, asymptomatic nature. Many people are unaware they are infected until complications arise.
  • Health Consequences:
    Chronic hepatitis B or C can lead to liver cirrhosis, liver cancer, or the need for a transplant.
  • Symptoms & Detection:
    Fatigue is a common but non-specific symptom. Routine blood tests (liver enzyme levels) are key for early detection.
  • High-Risk Groups:
    Includes people with HIV, those on dialysis, individuals with tattoos or past blood transfusions, and men who have sex with men.
  • Prevention:
    • Hepatitis A: Safe water and sanitation, vaccination.
    • Hepatitis B: Universal vaccination (especially at birth).
    • Hepatitis C: No vaccine; prevention relies on safe practices and screening.
  • Treatment Advances:
    • Hepatitis A: Symptomatic care.
    • Hepatitis B: Antiviral therapy to control the virus.
    • Hepatitis C: Curable with modern antiviral drugs (95–97% success rate).
  • Challenges:
    • Social stigma around hepatitis.
    • Need for broader screening and education.
    • Ensuring access to treatment, especially in low-resource settings.
    • Goal: Eliminate hepatitis as a public health threat by 2030.

Patient Perspective – Antonio Oñate

  • Diagnosis Journey:
    Diagnosed with hepatitis C in 2002 after abnormal liver tests. Likely contracted it from a blood transfusion in 1985.
  • Initial Challenges:
    • Lack of information and support.
    • High cost of treatment.
    • Emotional impact of a cold, discouraging diagnosis.
  • Treatment & Recovery:
    • Participated in a clinical trial in 2006 and was cured after 48 weeks of treatment.
    • Lifestyle changes and stress management helped improve his liver health even before treatment.
  • Advocacy & Awareness:
    • Became an activist to raise awareness and fight stigma.
    • Emphasizes the importance of early diagnosis and patient education.
  • Advice to Others:
    • Don’t lose hope.
    • Seek accurate information and support.
    • Be honest with healthcare providers.
    • “Hope is not a strategy, but it fuels the strategy.”

📢 Final Message

Hepatitis is preventable, treatable, and in many cases, curable. Early testing, vaccination, and access to treatment are essential. Join the global effort to eliminate hepatitis by 2030.